MANTLE-CELL LYMPHOMA
Clinical trials for MANTLE-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MANTLE-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MANTLE-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to control mantle cell lymphoma in older patients
Disease control Not yet recruitingThis study tests a combination of chemotherapy (bendamustine) and targeted drugs (orelabrutinib plus an anti-CD20 antibody) as a first treatment for mantle cell lymphoma in patients aged 65 and older, or those 60-64 who cannot have a stem cell transplant. The goal is to see if th…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
New hope for lymphoma patients when CAR T-Cell therapy Doesn't work
Disease control Not yet recruitingThis study tests a drug called glofitamab in 41 people with mantle cell lymphoma whose cancer did not respond or came back after CAR T-cell therapy. The goal is to see if glofitamab can shrink or control the cancer. Participants will receive the drug and be monitored for response…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Experimental NK cell cocktail aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis early-phase trial tests a combination of two antibody drugs (rituximab and tafasitamab) plus donated natural killer (NK) immune cells for people with B-cell non-Hodgkin lymphoma that has returned or not responded to at least two prior treatments. Up to 15 participants will r…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
Smart blood pressure cuffs could protect cancer patients from heart risks
Disease control Not yet recruitingThis study looks at whether using a connected blood pressure monitor at home can help catch and manage high blood pressure early in people with certain blood cancers (like CLL or lymphoma) who are starting a type of targeted therapy called BTK inhibitors. About 40 adults will use…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: NA • Sponsor: Centre Hospitalier de la côte Basque • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New hope for elderly lymphoma patients: targeted pill without chemo
Disease control Not yet recruitingThis study tests a daily pill called pirtobrutinib in elderly patients (70+) with mantle cell lymphoma who are too frail for standard chemotherapy. The goal is to see if the drug can control the cancer and delay its progression. About 56 participants will take the drug until thei…
Matched conditions: MANTLE-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 22, 2026 14:02 UTC